Misako Kawai Selected Research

AT1002

1/2021	Development of a Liquid Crystal Formulation that Can Penetrate the Stratum Corneum for Intradermal Delivery of Small Interfering RNA.
8/2011	Therapeutic effects on atopic dermatitis by anti-RelA short interfering RNA combined with functional peptides Tat and AT1002.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Misako Kawai Research Topics

Disease

2	Dysgeusia (Parageusia) 08/2021 - 03/2016
2	Head and Neck Neoplasms (Head and Neck Cancer) 08/2021 - 03/2016
2	Atopic Dermatitis (Atopic Eczema) 01/2021 - 08/2011
1	Skin Diseases (Skin Disease) 01/2021
1	Stomatitis 03/2016
1	Diarrhea 01/2010
1	Nausea 01/2010
1	Dizziness (Lightheadedness) 01/2010
1	Ageusia (Hypogeusia) 01/2010

Drug/Important Bio-Agent (IBA)

2	AT1002IBA 01/2021 - 08/2011
2	Peptides (Polypeptides)IBA 01/2021 - 08/2011
2	Small Interfering RNA (siRNA)IBA 01/2021 - 08/2011
1	Sodium Glutamate (Accent)IBA 08/2021
1	Trans-Activators (Trans-Acting Factor)IBA 01/2021
1	Messenger RNA (mRNA)IBA 03/2016
1	Therapeutic UsesIBA 08/2011
1	ParasympathomimeticsIBA 01/2010
1	Glutamic Acid (Glutamate)FDA Link 01/2010

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 08/2021 - 03/2016
1	Radiotherapy 03/2016
1	Chemoradiotherapy 03/2016